Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hepatitis

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 87 articles:
HTML format



Single Articles


    February 2024
  1. FRERICKS N, Brown RJP, Reinecke BM, Herrmann M, et al
    Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.
    J Virol. 2024 Feb 6:e0192123. doi: 10.1128/jvi.01921.
    PubMed     Abstract available


  2. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Correction for Nakajima et al., "Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations".
    J Virol. 2024 Feb 2:e0182323. doi: 10.1128/jvi.01823.
    PubMed    


    January 2024
  3. SHEN Z, Zhang S, Gao Z, Yu X, et al
    Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.
    J Virol. 2024 Jan 16:e0134523. doi: 10.1128/jvi.01345.
    PubMed     Abstract available


  4. MATRENEC R, Oropeza CE, Dekoven E, Tarnow G, et al
    Ten-eleven translocation (Tet) methylcytosine dioxygenase-dependent viral DNA demethylation mediates in vivo hepatitis B virus (HBV) biosynthesis.
    J Virol. 2024 Jan 5:e0172123. doi: 10.1128/jvi.01721.
    PubMed     Abstract available


  5. CASIANO MATOS J, Harichandran K, Tang J, Sviridov DO, et al
    Hepatitis C virus E1 recruits high-density lipoprotein to support infectivity and evade antibody recognition.
    J Virol. 2024 Jan 4:e0084923. doi: 10.1128/jvi.00849.
    PubMed     Abstract available


    December 2023
  6. HAGA Y, Meyer K, Sung MMH, Reagan EK, et al
    Hepatitis C virus modified sE2(F442NYT) as an antigen in candidate vaccine facilitates human immune cell activation.
    J Virol. 2023 Dec 12:e0180923. doi: 10.1128/jvi.01809.
    PubMed     Abstract available


  7. GOBRAN ST, Pagliuzza A, Khedr O, Fert A, et al
    DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people.
    J Virol. 2023 Dec 5:e0110523. doi: 10.1128/jvi.01105.
    PubMed     Abstract available


    November 2023
  8. BAJPAI PS, Collignon L, Solund C, Madsen LW, et al
    Full-length sequence analysis of hepatitis C virus genotype 3b strains and development of an in vivo infectious 3b cDNA clone.
    J Virol. 2023 Nov 21:e0092523. doi: 10.1128/jvi.00925.
    PubMed     Abstract available


  9. XU X, Zhang L, Ye G, Shi J, et al
    Hepatitis B doubly spliced protein (HBDSP) promotes hepatocellular carcinoma cell apoptosis via ETS1/GATA2/YY1-mediated p53 transcription.
    J Virol. 2023 Nov 6:e0108723. doi: 10.1128/jvi.01087.
    PubMed     Abstract available


    October 2023
  10. SEEGER C
    A CRISPR-based system to investigate HBV cccDNA biology.
    J Virol. 2023;97:e0118523.
    PubMed     Abstract available


  11. VANRUSSELT H, Kum DB, Taverniti V, Liu C, et al
    Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles.
    J Virol. 2023;97:e0072223.
    PubMed     Abstract available


  12. ARIFFIANTO A, Deng L, Abe T, Matsui C, et al
    Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication.
    J Virol. 2023 Oct 6:e0128723. doi: 10.1128/jvi.01287.
    PubMed     Abstract available


  13. LI Y, Yang Y, Li T, Wang Z, et al
    Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection.
    J Virol. 2023 Oct 3:e0109023. doi: 10.1128/jvi.01090.
    PubMed     Abstract available


    September 2023
  14. NEPAL S, Holmstrom ED
    Single-molecule-binding studies of antivirals targeting the hepatitis C virus core protein.
    J Virol. 2023 Sep 29:e0089223. doi: 10.1128/jvi.00892.
    PubMed     Abstract available


  15. XU L, Paine AC, Barbeau DJ, Alencastro F, et al
    Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
    J Virol. 2023;97:e0085323.
    PubMed     Abstract available


  16. SHEN S, Liu W, Zeng G, Liang H, et al
    Conditional replication and secretion of hepatitis B virus genome uncover the truncated 3' terminus of encapsidated viral pregenomic RNA.
    J Virol. 2023 Sep 27:e0076023. doi: 10.1128/jvi.00760.
    PubMed     Abstract available


  17. NAGASHIMA S, Primadharsini PP, Nishiyama T, Takahashi M, et al
    Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform.
    J Virol. 2023 Sep 8:e0050823. doi: 10.1128/jvi.00508.
    PubMed     Abstract available


    June 2023
  18. BERMUDEZ-MENDEZ E, Angelino P, van Keulen L, van de Water S, et al
    Transcriptomic Profiling Reveals Intense Host-Pathogen Dispute Compromising Homeostasis during Acute Rift Valley Fever Virus Infection.
    J Virol. 2023;97:e0041523.
    PubMed     Abstract available


  19. PANIGRAHI M, Palmer MA, Wilson JA
    Enhanced Virus Translation Enables miR-122-Independent Hepatitis C Virus Propagation.
    J Virol. 2023 Jun 20:e0085821. doi: 10.1128/jvi.00858.
    PubMed     Abstract available


  20. AVULA K, Singh B, Samantaray S, Syed GH, et al
    The Early Secretory Pathway Is Crucial for Multiple Aspects of the Hepatitis C Virus Life Cycle.
    J Virol. 2023 Jun 20:e0018023. doi: 10.1128/jvi.00180.
    PubMed     Abstract available


  21. YAO Q, Peng B, Li C, Li X, et al
    SLF2 Interacts with the SMC5/6 Complex to Direct Hepatitis B Virus Episomal DNA to Promyelocytic Leukemia Bodies for Transcriptional Repression.
    J Virol. 2023 Jun 20:e0032823. doi: 10.1128/jvi.00328.
    PubMed     Abstract available


  22. TOON K, Kalemera MD, Palor M, Rose NJ, et al
    GB Virus B and Hepatitis C Virus, Distantly Related Hepaciviruses, Share an Entry Factor, Claudin-1.
    J Virol. 2023 Jun 13:e0046923. doi: 10.1128/jvi.00469.
    PubMed     Abstract available


  23. ABE T, Marutani Y, Deng L, Matsui C, et al
    Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Calpha (PKCalpha) and PKCeta Expression, Thereby Promoting Viral Propagation.
    J Virol. 2023 Jun 5:e0065523. doi: 10.1128/jvi.00655.
    PubMed     Abstract available


    May 2023
  24. LIU C, Zhao K, Chen Y, Yao Y, et al
    Mitochondrial Glycerol-3-Phosphate Dehydrogenase Restricts HBV Replication via the TRIM28-Mediated Degradation of HBx.
    J Virol. 2023;97:e0058023.
    PubMed     Abstract available


  25. KUMAR A, Subramani C, Raj S, Ranjith-Kumar CT, et al
    Hepatitis E Virus Protease Inhibits the Activity of Eukaryotic Initiation Factor 2-Alpha Kinase 4 and Promotes Virus Survival.
    J Virol. 2023 May 18:e0034723. doi: 10.1128/jvi.00347.
    PubMed     Abstract available


    April 2023
  26. WOLFISBERG R, Holmbeck K, Billerbeck E, Thorselius CE, et al
    Molecular Determinants of Mouse Adaptation of Rat Hepacivirus.
    J Virol. 2023;97:e0181222.
    PubMed     Abstract available


  27. ZHU X, Guan Z, Fang Y, Zhang Y, et al
    Rift Valley Fever Virus Nucleoprotein Triggers Autophagy to Dampen Antiviral Innate Immune Responses.
    J Virol. 2023;97:e0181422.
    PubMed     Abstract available


    March 2023
  28. ZAIETS I, Gunewardena S, Menne S, Weinman SA, et al
    Sera of Individuals Chronically Infected with Hepatitis B Virus (HBV) Contain Diverse RNA Types Produced by HBV Replication or Derived from Integrated HBV DNA.
    J Virol. 2023 Mar 6:e0195022. doi: 10.1128/jvi.01950.
    PubMed     Abstract available


    February 2023
  29. SASAKI-TANAKA R, Masuzaki R, Okamoto H, Shibata T, et al
    Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
    J Virol. 2023 Feb 2:e0198722. doi: 10.1128/jvi.01987.
    PubMed     Abstract available


    January 2023
  30. GLASSMAN KF, Brugge JS, Purchio AF, Kakach LT, et al
    Biographical Feature: Marc S. Collett (23 May 1951-11 June 2022): the Battle against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a Splendid Human Being.
    J Virol. 2023;97:e0164322.
    PubMed    


    December 2022
  31. KANAI T, Hu Z, Yang R, Wu W, et al
    Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis.
    J Virol. 2022 Dec 15:e0178822. doi: 10.1128/jvi.01788.
    PubMed     Abstract available


  32. TANG L, An P, Zhao Q, Winkler CA, et al
    Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
    J Virol. 2022 Dec 15:e0126122. doi: 10.1128/jvi.01261.
    PubMed     Abstract available


  33. PENG B, Jing Z, Zhou Z, Sun Y, et al
    Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
    J Virol. 2022 Dec 7:e0171722. doi: 10.1128/jvi.01717.
    PubMed     Abstract available


    November 2022
  34. ZHAO Q, Chang J, Rijnbrand R, Lam AM, et al
    Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
    J Virol. 2022 Nov 30:e0115022. doi: 10.1128/jvi.01150.
    PubMed     Abstract available


  35. CHEN Y, Wang B, Ou X, Wu Y, et al
    Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling.
    J Virol. 2022 Nov 17:e0102022. doi: 10.1128/jvi.01020.
    PubMed     Abstract available


  36. SHIOTA T, Matsuda M, Zheng X, Nagata N, et al
    Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in Ifnar1(-/-) Mice.
    J Virol. 2022 Nov 10:e0149622. doi: 10.1128/jvi.01496.
    PubMed     Abstract available


    October 2022
  37. SACCO MT, Bland KM, Horner SM
    WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
    J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
    PubMed     Abstract available


  38. SCHWARZ MM, Connors KA, Davoli KA, McMillen CM, et al
    Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease.
    J Virol. 2022;96:e0111222.
    PubMed     Abstract available


  39. ZHONG Y, Wu C, Xu Z, Teng Y, et al
    Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
    J Virol. 2022 Oct 13:e0136222. doi: 10.1128/jvi.01362.
    PubMed     Abstract available


    September 2022
  40. LIU Y, Kornyeyev D, May L, Han D, et al
    Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System.
    J Virol. 2022;96:e0084922.
    PubMed     Abstract available


  41. KIM GW, Moon JS, Gudima SO, Siddiqui A, et al
    N(6)-Methyladenine Modification of Hepatitis Delta Virus Regulates Its Virion Assembly by Recruiting YTHDF1.
    J Virol. 2022 Sep 14:e0112422. doi: 10.1128/jvi.01124.
    PubMed     Abstract available


  42. SOORYANARAIN H, Heffron CL, Mahsoub HM, Hassebroek AM, et al
    Modulation of SOCS3 Levels via STAT3 and Estrogen-ERalphap66 Signaling during Hepatitis E Virus Replication in Hepatocellular Carcinoma Cells.
    J Virol. 2022 Sep 14:e0100822. doi: 10.1128/jvi.01008.
    PubMed     Abstract available


    August 2022
  43. SASAKI-TANAKA R, Shibata T, Moriyama M, Okamoto H, et al
    Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
    J Virol. 2022 Aug 30:e0064622. doi: 10.1128/jvi.00646.
    PubMed     Abstract available


  44. JIANG J, Hao Y, He B, Su L, et al
    Severe Acute Hepatitis Outbreaks Associated with a Novel Hepacivirus in Rhizomys pruinosus in Hainan, China.
    J Virol. 2022 Aug 25:e0078222. doi: 10.1128/jvi.00782.
    PubMed     Abstract available


  45. ROGIER E, Plucinski M, Candrinho B, Moss DM, et al
    Adaptation to a Multiplex Bead Assay and Seroprevalence to Rift Valley Fever N Protein: Nampula Province, Mozambique, 2013-2014.
    J Virol. 2022;96:e0067222.
    PubMed     Abstract available


  46. WANG XQ, Zerbato JM, Avihingsanon A, Fisher K, et al
    Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
    J Virol. 2022 Aug 2:e0058822. doi: 10.1128/jvi.00588.
    PubMed     Abstract available


    July 2022
  47. HONG X, Hu J
    Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation.
    J Virol. 2022 Jul 18:e0071822. doi: 10.1128/jvi.00718.
    PubMed     Abstract available


  48. CHEN Y, Yao Y, Zhao K, Liu C, et al
    DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    J Virol. 2022;96:e0058522.
    PubMed     Abstract available


    June 2022
  49. WU Q, Zhang L, Xu X, Zhang Y, et al
    Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.
    J Virol. 2022 Jun 13:e0061122. doi: 10.1128/jvi.00611.
    PubMed     Abstract available


  50. LI Y, He M, Gong R, Wang Z, et al
    Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Inter
    J Virol. 2022 Jun 13:e0054622. doi: 10.1128/jvi.00546.
    PubMed     Abstract available


    May 2022
  51. VIJAYAMAHANTESH V, Patra T, Meyer K, Alameh MG, et al
    Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response.
    J Virol. 2022 May 25:e0052322. doi: 10.1128/jvi.00523.
    PubMed     Abstract available


    April 2022
  52. PLEY C, Lourenco J, McNaughton AL, Matthews PC, et al
    Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?
    J Virol. 2022 Apr 12:e0005122. doi: 10.1128/jvi.00051.
    PubMed     Abstract available


  53. XI J, Cui X, Liu K, Liu H, et al
    Region-Specific Hepatitis B Virus Genome Exposure from Nucleocapsid Modulated by Capsid Linker Sequence and Inhibitor: Implications for Uncoating.
    J Virol. 2022 Apr 7:e0039922. doi: 10.1128/jvi.00399.
    PubMed     Abstract available


    March 2022
  54. WAN H, Adams RL, Lindenbach BD, Pyle AM, et al
    The In Vivo and In Vitro Architecture of the Hepatitis C Virus RNA Genome Uncovers Functional RNA Secondary and Tertiary Structures.
    J Virol. 2022 Mar 30:e0194621. doi: 10.1128/jvi.01946.
    PubMed     Abstract available


  55. REINECKE B, Frericks N, Lauber C, Dinkelborg K, et al
    The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
    J Virol. 2022 Mar 17:e0199521. doi: 10.1128/jvi.01995.
    PubMed     Abstract available


  56. YU CC, Lin PC, Chiang CH, Jen ST, et al
    Sequential Phosphorylation of Hepatitis C Virus NS5A Protein Requires the ATP-Binding Domain of NS3 Helicase.
    J Virol. 2022 Mar 16:e0010722. doi: 10.1128/jvi.00107.
    PubMed     Abstract available


  57. TAKEMORI T, Sugimoto-Ishige A, Nishitsuji H, Futamura Y, et al
    Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
    J Virol. 2022;96:e0168621.
    PubMed     Abstract available


    February 2022
  58. PRIMADHARSINI PP, Nagashima S, Nishiyama T, Takahashi M, et al
    Development of recombinant infectious hepatitis E virus harboring the nanoKAZ gene and its application in drug screening.
    J Virol. 2022 Feb 2:jvi0190621. doi: 10.1128/jvi.01906.
    PubMed     Abstract available


    January 2022
  59. KIM C, Barnes LF, Schlicksup CJ, Patterson AJ, et al
    Core Protein-Directed Antivirals and Importin beta Can Synergistically Disrupt Hepatitis B Virus Capsids.
    J Virol. 2022;96:e0139521.
    PubMed     Abstract available


  60. MARCHETTI AL, Zhang H, Kim ES, Yu X, et al
    Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    J Virol. 2022;96:e0136021.
    PubMed     Abstract available


  61. DENG L, Liang Y, Ariffianto A, Matsui C, et al
    Hepatitis C virus (HCV)-induced ROS/JNK signaling pathway activates the E3 ubiquitin ligase Itch to promote the release of HCV particles via polyubiquitylation of VPS4A.
    J Virol. 2022 Jan 19:JVI0181121. doi: 10.1128/JVI.01811.
    PubMed     Abstract available


  62. ZHANG J, Yuan Q, Wang Y, Wang Y, et al
    5' preS1 mutations to prevent large envelope protein expression from hepatitis B virus genotype A or genotype D markedly increase polymerase-envelope fusion protein.
    J Virol. 2022 Jan 12:JVI0172321. doi: 10.1128/JVI.01723.
    PubMed     Abstract available


  63. MCGREGOR J, Hardy JM, Lay CS, Boo I, et al
    Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
    J Virol. 2022 Jan 5:JVI0167521. doi: 10.1128/JVI.01675.
    PubMed     Abstract available


    December 2021
  64. WU SX, Ye SS, Hong YX, Chen Y, et al
    Hepatitis B virus small envelope protein promotes HCC angiogenesis via ER stress signaling to upregulate VEGFA expression.
    J Virol. 2021 Dec 15:JVI0197521. doi: 10.1128/JVI.01975.
    PubMed     Abstract available


  65. PANIGRAHI M, Thibault PA, Wilson JA
    miR-122 affects both the initiation and maintenance of Hepatitis C Virus infections.
    J Virol. 2021 Dec 15:JVI0190321. doi: 10.1128/JVI.01903.
    PubMed     Abstract available


  66. STEPHENSON-TSORIS S, Casey JL
    Hepatitis delta virus genome RNA synthesis initiates at position 1646 with a non-templated guanosine.
    J Virol. 2021 Dec 8:JVI0201721. doi: 10.1128/JVI.02017.
    PubMed     Abstract available


  67. KIM GW, Siddiqui A
    Hepatitis B virus X (HBx) Protein Expression is Tightly Regulated by N6-methyladenosine Modification of its mRNA.
    J Virol. 2021 Dec 1:JVI0165521. doi: 10.1128/JVI.01655.
    PubMed     Abstract available


    November 2021
  68. BARBEAU DJ, Cartwright HN, Harmon JR, Spengler JR, et al
    Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.
    J Virol. 2021;95:e0150621.
    PubMed     Abstract available


  69. KHATUN M, Kumar K, Baidya A, Mondal RK, et al
    Variability in the response of HBV D-subgenotypes to antiviral therapy: designing pan D-subgenotypic reverse transcriptase inhibitors.
    J Virol. 2021 Nov 3:JVI0180021. doi: 10.1128/JVI.01800.
    PubMed     Abstract available


    October 2021
  70. XI J, Liu H, Hu J
    Regulation of Hepatitis B Virus Virion Release and Envelopment Timing by Nucleocapsid and Envelope Interactions.
    J Virol. 2021 Oct 13:JVI0130521. doi: 10.1128/JVI.01305.
    PubMed     Abstract available


  71. FUKANO K, Oshima M, Tsukuda S, Aizaki H, et al
    NTCP oligomerization occurs downstream of the NTCP-EGFR interaction during hepatitis B virus internalization.
    J Virol. 2021 Oct 6:JVI0093821. doi: 10.1128/JVI.00938.
    PubMed     Abstract available


    September 2021
  72. ZOU S, Du Y, Huang S, Chen M, et al
    Simultaneous or prior activation of intrahepatic type I interferon signaling leads to hepatitis B virus persistence in a mouse model.
    J Virol. 2021 Sep 22:e0003421. doi: 10.1128/JVI.00034.
    PubMed     Abstract available


  73. SARI G, Zhu J, Ambardekar C, Yin X, et al
    The viral ORF3 protein is required for hepatitis E virus apical release and efficient growth in polarized hepatocytes and humanized mice.
    J Virol. 2021 Sep 15:JVI0058521. doi: 10.1128/JVI.00585.
    PubMed     Abstract available


  74. RAMIREZ R, van Buuren N, Gamelin L, Soulette C, et al
    Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.
    J Virol. 2021;95:e0029921.
    PubMed     Abstract available


    July 2021
  75. TARNOW G, McLachlan A
    B-Catenin Signaling Regulates the In Vivo Distribution of Hepatitis B Virus Biosynthesis across the Liver Lobule.
    J Virol. 2021 Jul 28:JVI0078021. doi: 10.1128/JVI.00780.
    PubMed     Abstract available


  76. MAO R, Dong M, Shen Z, Zhang H, et al
    RNA Helicase DDX17 inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.
    J Virol. 2021 Jul 21:JVI0044421. doi: 10.1128/JVI.00444.
    PubMed     Abstract available


    June 2021
  77. LIU F, Lee ACH, Guo F, Kondratowicz AS, et al
    Host poly(A) polymerases PAPD5 and PAPD7 provide two layers of protection that ensure the integrity and stability of hepatitis B virus RNA.
    J Virol. 2021 Jun 30:JVI0057421. doi: 10.1128/JVI.00574.
    PubMed     Abstract available


  78. KHATUN M, Zhang J, Ray R, Ray RB, et al
    Hepatitis C virus evades IFN signaling by suppressing long non-coding RNA Linc-Pint involving c/EBP-beta.
    J Virol. 2021 Jun 23:JVI0095221. doi: 10.1128/JVI.00952.
    PubMed     Abstract available


  79. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Biochemical and structural properties of entecavir-resistant hepatitis B virus polymerase with L180M/M204V mutations.
    J Virol. 2021 Jun 2:JVI0240120. doi: 10.1128/JVI.02401.
    PubMed     Abstract available


    May 2021
  80. LIU H, Xi J, Hu J
    Regulation of Hepatitis B Virus Replication by Cyclin Docking Motifs in Core Protein.
    J Virol. 2021;95.
    PubMed     Abstract available


  81. VOTH LS, O'Connor JJ, Kerr CM, Doerger E, et al
    Unique mutations in the MHV macrodomain differentially attenuate virus replication, indicating multiple roles for the macrodomain in coronavirus replication.
    J Virol. 2021 May 19. pii: JVI.00766-21. doi: 10.1128/JVI.00766.
    PubMed     Abstract available


  82. IBRAHIM MK, Abdelhafez TH, Takeuchi JS, Wakae K, et al
    MafF is an antiviral host factor that suppresses transcription from Hepatitis B Virus core promoter.
    J Virol. 2021 May 12. pii: JVI.00767-21. doi: 10.1128/JVI.00767.
    PubMed     Abstract available


  83. MISUMI I, Li Z, Sun L, Das A, et al
    Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected Ifnar1(-/-) Mice.
    J Virol. 2021;95:e0005821.
    PubMed     Abstract available


    April 2021
  84. FU S, Zhang J, Yuan Q, Wang Q, et al
    Lost small envelope protein expression from naturally occurring preS1 deletion mutants of hepatitis B virus is often accompanied by increased HBx and core protein expression as well as genome replication.
    J Virol. 2021 Apr 28. pii: JVI.00660-21. doi: 10.1128/JVI.00660.
    PubMed     Abstract available


  85. REINHARZ V, Ishida Y, Tsuge M, Durso-Cain K, et al
    Understanding hepatitis B virus dynamics and the antiviral effect of interferon-alpha treatment in humanized chimeric mice.
    J Virol. 2021 Apr 28. pii: JVI.00492-20. doi: 10.1128/JVI.00492.
    PubMed     Abstract available


  86. KIM GW, Imam H, Siddiqui A
    The RNA binding proteins YTHDC1 and FMRP regulate the nuclear export of N6-methyladenosine modified Hepatitis B Virus transcripts and affect the viral life cycle.
    J Virol. 2021 Apr 21. pii: JVI.00097-21. doi: 10.1128/JVI.00097.
    PubMed     Abstract available


  87. MCMILLEN CM, Hartman AL
    Rift Valley Fever: a Threat to Pregnant Women Hiding in Plain Sight?
    J Virol. 2021;95.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.